Caspr2 as an autism candidate gene: a proteomic approach to function & structure.

Caspr2 作为自闭症候选基因：功能的蛋白质组学方法

• 批准号: 8041617
• 负责人: Davide Comoletti
• 金额: $ 31.2万
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-01 至 2016-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8041617
• 关键词: Adhesives; Affect; Amino Acid Substitution; Attention deficit hyperactivity disorder; Autistic Disorder; Biochemical; Biological Process; Biology; Brain; Candidate Disease Gene; Cell Adhesion Molecules; Cell Communication; Cells; Coculture Techniques; Code; Collaborations; Complex; Copy Number Polymorphism; Crystallography; Data; Databases; Deuterium; Development; Dimensions; Disease; Drug Delivery Systems; Electron Microscopy; Epilepsy; Excitatory Synapse; Extracellular Domain; France; Functional disorder; Future; Genes; Genetic; Genetic Polymorphism; Gilles de la Tourette syndrome; Hippocampus (Brain); Human; Hydrogen; Language Delays; Link; Location; Molecular; Mutation; Mutation Analysis; NRCAM gene; Negative Staining; Neuraxis; Neurodevelopmental Disorder; Neurons; Pathogenesis; Patients; Peripheral Nervous System; Population; Process; Property; Protein Biosynthesis; Proteins; Proteomics; Ranvier' s Nodes; Research Personnel; Resolution; Rodent; Roentgen Rays; Role; Schizophrenia; Severities; Site; Staging; Structure; Synapses; Synaptic Potentials; System; TAG-1 axonal glycoprotein; Technology; Therapeutic; Therapeutic Intervention; Work; autism spectrum disorder; base; contactin; design; disorder risk; genetic linkage; improved; insight; instrumentation; mutant; neuroligin 1; neuroligin 3; neuronal cell body; particle; protein function; protein structure; protein transport; research study; three dimensional structure; trafficking

DESCRIPTION (provided by applicant): Several lines of evidence imply that autism, epilepsy, and schizophrenia may share some underlying brain abnormalities. Recent genetic studies suggest that mutations of Caspr2, gene product of CNTNAP2, increase the disease risk of these common manifestations. At the protein level, the role of Caspr2 in the rodent peripheral nervous system is established. In the human CNS, however, no information on the role of this protein and its neuronal location is thus far available. Recent studies suggest that Caspr2 is a key molecule in cell-cell interactions important for normal neuronal function and cortical development. To understand the structure of this protein and its functions in the human brain, we propose the following: 1) Study the three-dimensional structure of the extracellular domain of Caspr2. As the atomic structure of a protein drives its function, Caspr2 structure will enable us to improve our understanding of the biology of this neuronal protein and to predict how mutations linked to a disease state affect Caspr2 structure and function, thus setting the basis for future drug targets identification for epilepsy and autism. 2) Investigate the role of Caspr2 in hippocampal neurons and the biochemical and cellular consequences of mutations of human Caspr2 linked to ASD. Because mutations found in the human population affect the biological function of Caspr2, analysis of these mutations promises to yield critical insights into the neuronal anomalies that give rise to aberrations in neuronal connectivity, and may provide a basis for designing specific therapeutic interventions. PUBLIC HEALTH RELEVANCE: Several lines of evidence indicate that autism, epilepsy, ADHD, Tourette syndrome, and schizophrenia share some common underlying brain abnormalities. Recent genetic studies suggest that mutations or copy number variation in the CNTNAP2 gene may cause some of these manifestations. The studies of the structure and the deleterious effects of the known mutations of Caspr2 (gene product of CNTNAP2) will help understanding the biology of this neuronal protein and predict how mutations linked to a disease state affect Caspr2 structure and function. Ultimately, these data will help researchers to develop therapeutic strategies to modify protein biosynthesis, processing, or adhesive properties of the partnering proteins to ameliorate these disorders.

描述(由申请人提供)：几行证据表明，自闭症、癫痫和精神分裂症可能共享一些潜在的大脑异常。最近的遗传学研究表明，CNTNAP2的基因产物Caspr2的突变增加了这些常见症状的患病风险。在蛋白质水平上，确定了Caspr2在啮齿动物周围神经系统中的作用。然而，到目前为止，在人类中枢神经系统中，还没有关于该蛋白的作用及其神经元位置的信息。最近的研究表明，Caspr2是细胞间相互作用的关键分子，对正常的神经元功能和皮质发育至关重要。为了了解该蛋白的结构及其在人脑中的功能，我们提出了以下建议：1)研究Caspr2胞外结构域的三维结构。由于蛋白质的原子结构驱动其功能，Caspr2结构将使我们能够更好地理解这种神经元蛋白质的生物学特性，并预测与疾病状态相关的突变如何影响Caspr2结构和功能，从而为未来癫痫和自闭症的药物靶点识别奠定基础。2)研究Caspr2在海马神经元中的作用以及与ASD相关的人Caspr2突变的生化和细胞后果。由于在人类群体中发现的突变会影响Caspr2的生物学功能，对这些突变的分析有望对导致神经元连接异常的神经元异常产生关键的见解，并可能为设计特定的治疗干预措施提供基础。 与公共卫生相关：有几条证据表明，自闭症、癫痫、多动症、抽动症和精神分裂症有一些共同的潜在大脑异常。最近的遗传学研究表明，CNTNAP2基因的突变或拷贝数变异可能导致其中一些症状。对Caspr2(CNTNAP2的基因产物)已知突变的结构和危害的研究将有助于了解这种神经元蛋白的生物学特性，并预测与疾病状态相关的突变如何影响Caspr2的结构和功能。最终，这些数据将帮助研究人员开发治疗策略，以改变蛋白质的生物合成、加工或伙伴蛋白质的粘附性，以改善这些疾病。